Cytokinetics (Switzerland) GmbH

Cytokinetics (Switzerland) GmbH is a specialty cardiovascular biopharmaceutical company focused on developing innovative treatments for patients with cardiac muscle dysfunction. With over 25 years of experience in pioneering scientific innovations in muscle biology, the company is dedicated to advancing a pipeline of potential new medicines. The company operates primarily in the DACH region, emphasizing its commitment to improving patient outcomes through targeted therapies.